206 related articles for article (PubMed ID: 19060033)
1. Effectiveness of chlamydia screening: systematic review.
Low N; Bender N; Nartey L; Shang A; Stephenson JM
Int J Epidemiol; 2009 Apr; 38(2):435-48. PubMed ID: 19060033
[TBL] [Abstract][Full Text] [Related]
2. Screening for chlamydial infection.
Nelson HD; Helfand M
Am J Prev Med; 2001 Apr; 20(3 Suppl):95-107. PubMed ID: 11306238
[TBL] [Abstract][Full Text] [Related]
3. Screening and treating Chlamydia trachomatis genital infection to prevent pelvic inflammatory disease: interpretation of findings from randomized controlled trials.
Gottlieb SL; Xu F; Brunham RC
Sex Transm Dis; 2013 Feb; 40(2):97-102. PubMed ID: 23324973
[TBL] [Abstract][Full Text] [Related]
4. The program cost and cost-effectiveness of screening men for Chlamydia to prevent pelvic inflammatory disease in women.
Gift TL; Gaydos CA; Kent CK; Marrazzo JM; Rietmeijer CA; Schillinger JA; Dunne EF
Sex Transm Dis; 2008 Nov; 35(11 Suppl):S66-75. PubMed ID: 18830137
[TBL] [Abstract][Full Text] [Related]
5. Early screening for Chlamydia trachomatis in young women for primary prevention of pelvic inflammatory disease (i-Predict): study protocol for a randomised controlled trial.
Tamarelle J; Thiébaut ACM; Sabin B; Bébéar C; Judlin P; Fauconnier A; Rahib D; Méaude-Roufai L; Ravel J; Morré SA; de Barbeyrac B; Delarocque-Astagneau E;
Trials; 2017 Nov; 18(1):534. PubMed ID: 29132441
[TBL] [Abstract][Full Text] [Related]
6. Screening and treatment to prevent sequelae in women with Chlamydia trachomatis genital infection: how much do we know?
Gottlieb SL; Berman SM; Low N
J Infect Dis; 2010 Jun; 201 Suppl 2():S156-67. PubMed ID: 20470051
[TBL] [Abstract][Full Text] [Related]
7. Cost effectiveness of home based population screening for Chlamydia trachomatis in the UK: economic evaluation of chlamydia screening studies (ClaSS) project.
Roberts TE; Robinson S; Barton PM; Bryan S; McCarthy A; Macleod J; Egger M; Low N
BMJ; 2007 Aug; 335(7614):291. PubMed ID: 17656504
[TBL] [Abstract][Full Text] [Related]
8. Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial.
Oakeshott P; Kerry S; Aghaizu A; Atherton H; Hay S; Taylor-Robinson D; Simms I; Hay P
BMJ; 2010 Apr; 340():c1642. PubMed ID: 20378636
[TBL] [Abstract][Full Text] [Related]
9. Preventing infective sequelae of abortion.
Penney GC
Hum Reprod; 1997 Nov; 12(11 Suppl):107-12. PubMed ID: 9433966
[TBL] [Abstract][Full Text] [Related]
10. Screening for chlamydia and/or gonorrhea in primary health care: systematic reviews on effectiveness and patient preferences.
Pillay J; Wingert A; MacGregor T; Gates M; Vandermeer B; Hartling L
Syst Rev; 2021 Apr; 10(1):118. PubMed ID: 33879251
[TBL] [Abstract][Full Text] [Related]
11. [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women].
Ruitenberg EN
Ned Tijdschr Geneeskd; 1999 May; 143(19):1012. PubMed ID: 10368724
[No Abstract] [Full Text] [Related]
12. Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening.
Land JA; Van Bergen JE; Morré SA; Postma MJ
Hum Reprod Update; 2010; 16(2):189-204. PubMed ID: 19828674
[TBL] [Abstract][Full Text] [Related]
13. Screening for Chlamydial and Gonococcal Infections: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Cantor A; Dana T; Griffin JC; Nelson HD; Weeks C; Winthrop KL; Chou R
JAMA; 2021 Sep; 326(10):957-966. PubMed ID: 34519797
[TBL] [Abstract][Full Text] [Related]
14. Screening for gonorrhea and Chlamydia: a systematic review for the U.S. Preventive Services Task Force.
Zakher B; Cantor AG; Pappas M; Daeges M; Nelson HD
Ann Intern Med; 2014 Dec; 161(12):884-93. PubMed ID: 25244000
[TBL] [Abstract][Full Text] [Related]
15. [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women].
Postma MJ; Welte R; van den Hoek JA; van Doornum GJ; Coutinho RA; Jager JC
Ned Tijdschr Geneeskd; 1999 Mar; 143(13):677-81. PubMed ID: 10321301
[TBL] [Abstract][Full Text] [Related]
16. The cost and cost-effectiveness of opportunistic screening for Chlamydia trachomatis in Ireland.
Gillespie P; O'Neill C; Adams E; Turner K; O'Donovan D; Brugha R; Vaughan D; O'Connell E; Cormican M; Balfe M; Coleman C; Fitzgerald M; Fleming C
Sex Transm Infect; 2012 Apr; 88(3):222-8. PubMed ID: 22213681
[TBL] [Abstract][Full Text] [Related]
17. Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes--implications for cost-effectiveness analyses.
van Valkengoed IG; Morré SA; van den Brule AJ; Meijer CJ; Bouter LM; Boeke AJ
Int J Epidemiol; 2004 Apr; 33(2):416-25. PubMed ID: 15082651
[TBL] [Abstract][Full Text] [Related]
18. Commentary: Chlamydia trachomatis screening: what are we trying to do?
Peterman TA; Gottlieb SL; Berman SM
Int J Epidemiol; 2009 Apr; 38(2):449-51. PubMed ID: 19174542
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
